Polyglandular Syndrome type III in a young patient: case report
Síndrome Poliglandular tipo III em paciente jovem: relato de caso
Palavras-chave:
Autoimmune Polyendocrinopathy, Hypothyroidism, Pernicious Anemia, Systemic Lupus Erythematosus, Drug-Related Side Effects, Adverse ReactionsResumo
Introduction: Autoimmune polyglandular syndromes (APS) are rare diseases defined by the coexistence of at least two autoimmune endocrine diseases. Objective: To describe a case of type III polyglandular syndrome in a young patient. Case report: Female, 37 years old, with hypothyroidism, presented with a weight loss of 9 kg, daily vomiting, asthenia, fatigue, and postprandial fullness for 3 months. He also reported arthritis in his wrists, shoulders, and hips. In laboratory tests, macrocytic and hyperchromic anemia associated with leukopenia, as well as hypovitaminosis B12, was observed. Pernicious anemia was investigated as the cause of this deficiency. Upper digestive endoscopy showed moderate gastritis – histopathological with gastric atrophy, positive anti-intrinsic factor antibody. Due to inflammatory arthralgia, ANA was requested, with an associated positive anti-dsDNA result of 1:80. In the EULAR/2019 diagnostic criteria for Systemic Lupus Erythematosus (SLE), she presented 14 points, thus she was diagnosed with SLE, and hydroxychloroquine (HXC) was started. Conclusion: SPA is rare, mainly in association with non-glandular autoimmunity, following an early diagnosis.
Downloads
Referências
ABDELBAKY, Mohammed Salah Eldin et al. Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus. The Egyptian Journal of Internal Medicine, v. 33, n. 1, p. 1-9, 2021.
APOLINARIO, Michael et al. Autoimmune polyglandular syndrome type 3: A case report of an unusual presentation and literature review. Clinical Case Reports, v. 10, n. 2, p. e05391, 2022.
ASHRAF, T. Soliman et al. Chronic anemia and thyroid function. Acta Bio Medica: Atenei Parmensis, v. 88, n. 1, p. 119, 2017.
BETTERLE, Corrado; ZANCHETTA, Renato. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed, v. 74, n. 1, p. 9-33, 2003.
BUTLER, Christopher C et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Family Practice, v. 23, n. 3, p. 279-285, 2006.
CHECCHI, Serenella et al. L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. The Journal of Clinical Endocrinology & Metabolism, v. 93, n. 2, p. 465-469, 2008.
DE CARVALHO, Gisah Amaral et al. Management of endocrine disease: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults. European Journal of Endocrinology, v. 178, n. 6, p. R231-R244, 2018.
DIMA, Alina et al. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Therapeutic Advances in Musculoskeletal Disease, v. 14, p. 1759720X211073001, 2022.
DUNTAS, Leonidas H.; YEN, Paul Michael. Diagnosis and treatment of hypothyroidism in the elderly. Endocrine, v. 66, n. 1, p. 63-69, 2019.
DURCAN, Laura; O'DWYER, Tom; PETRI, Michelle. Management strategies and future directions for systemic lupus erythematosus in adults. The Lancet, v. 393, n. 10188, p. 2332-2343, 2019.
FANOURIAKIS, Antonis; KOSTOPOULOU, Myrto; ALUNNO, Alessia et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Disease, v. 78. p. 736-745, 2019.
FAN, Yong; HAO, Yan-Jie; ZHANG, Zhuo-Li. Systemic lupus erythematosus: year in review 2019. Chinese Medical Journal, v. 133, n. 18, p. 2189-2196, 2020.
FAVA, Andrea; PETRI, Michelle. Systemic lupus erythematosus: diagnosis and clinical management. Journal of Autoimmunity, v. 96, p. 1-13, 2019.
FORTUNA, Giulio; BRENNAN, Michael T. Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management. Dental Clinics, v. 57, n. 4, p. 631-655, 2013.
GLADMAN, Dafna D.; IBANEZ, Dominique; UROWITZ, Murray B. Systemic lupus erythematosus disease activity index 2000. The Journal of Rheumatology, v. 29, n. 2, p. 288-291, 2002.
GLASS, George B. Jerzy; SKEGGS, Helen R.; LEE, Duk Ho. Hydroxocobalamin: V. Prolonged maintenance of high vitamin B12 blood levels following a short course of hydroxocobalamin injections. Blood, v. 27, n. 2, p. 234-241, 1966.
GONZALES, Kristen M. et al. The levothyroxine absorption test: a four-year experience (2015–2018) at the Mayo Clinic. Thyroid, v. 29, n. 12, p. 1734-1742, 2019.
HORINO, Taro; OGASAWARA, Masami; ICHII, Osamu et al. Autoimmune polyglandular syndrome type 3 variant in rheumatoid arthritis. Romanian Journal of Internal Medicine, v. 58, n. 1, p. 40-43, 2020.
JAMESON, J. Larry et al. Manual de Medicina de Harrison. 20ª edição, McGraw Hill Brasil, 2020.
JAMIL, Muhammad Zahid Z et al. Determining the Association Between Helicobacter pylori Infection and Treatment-Refractory Hypothyroidism. Cureus, v. 14, n. 1, 2022.
JESUS, Diogo et al. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Annals of the Rheumatic Diseases, v. 80, n. 12, p. 1568-1574, 2021.
JONKLAAS, Jacqueline et al. Guidelines for the Treatment of Hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. thyroid, v. 24, n. 12, p. 1670-1751, 2014.
KAHALY, G. J.; FROMMER, L. Polyglandular autoimmune syndromes. Journal of Endocrinological Investigation, v. 41, n. 1, p. 91-98, 2018.
MARTINS, Mílton de Arruda. Manual do Residente de Clínica Médica. BARUERI: Manole, 2ª edição atualizada, p. 1456, 2021.
NAVARRETE-TAPIA, Ulises. Síndrome poliglandular autoinmune. Revista Médica del Hospital General de México, v. 76, n. 3, p. 143-52, 2013.
ROBINSON, J. Daniel et al. Determination of ideal body weight for drug dosage calculations. American Journal of Hospital Pharmacy, v. 40, n. 6, p. 1016-1019, 1983.
RODRÍGUEZ-GONZÁLEZ, Melissa G. et al. Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population. Annals of the Rheumatic Diseases, v. 79, n. 12, p. e158-e158, 2020.
SCHREZENMEIER, Eva; DÖRNER, Thomas. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nature Reviews Rheumatology, v. 16, n. 3, p. 155-166, 2020.
TAVARES, Jamila Vaz; KAHWAGE, Amanda Machado. Síndrome poliglandular autoimune tipo III: uma rara associação entre doença de graves, vitiligo e miastenia gravis. Revista Eletrônica Acervo Saúde, v. 11, n. 5, p. e245-e245, 2019.
TINCANI, Angela et al. Autoimmune polyendocrine syndromes. In: Diagnostic Criteria in Autoimmune Diseases. Humana Press, p. 265-269, 2008.
VAN WILDER, Nancy et al. Pseudomalabsorption of levothyroxine: a challenge for the endocrinologist in the treatment of hypothyroidism. European Thyroid Journal, v. 6, n. 1, p. 52-56, 2017.
VASCONCELOS, José Tupinambé Sousa; NETO, João Francisco Marques; SHINJO, Samuel Katsuyuki; et al. Livro da Sociedade Brasileira de Reumatologia. 2ª ed. Barueri: Manole, 2020.
VILAR, Lucio. Endocrinologia Clínica 6ª edição , 2016.
VIRILI, Camilla et al. Levothyroxine treatment and gastric juice pH in humans: the proof of concept. Endocrine, p. 1-10, 2022.
WALKER, J. N. et al. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. European Journal of Endocrinology, v. 168, n. 6, p. 913-917, 2013.
